Global (United States, European Union and China) GABA (Gamma-Aminobutyric Acid) Market Research Report 2019-2025

GAMMA-Aminobutyric acid, or γ-aminobutyric acid or GABA, is the chief inhibitory neurotransmitter in the mammalian central nervous system.
Its principal role is reducing neuronal excitability throughout the nervous system. In humans, GABA is also directly responsible for the regulation of muscle tone.
In 2019, the market size of GABA (Gamma-Aminobutyric Acid) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for GABA (Gamma-Aminobutyric Acid).

This report studies the global market size of GABA (Gamma-Aminobutyric Acid), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the GABA (Gamma-Aminobutyric Acid) production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Novartis
Ovation Pharmaceuticals
Pfizer
Sanofi
Vivus
Astrazeneca
Elan
Eli Lilly
Glaxosmithkline

Market Segment by Product Type
Chemical Synthesis
Biological Fermentation

Market Segment by Application
Pharmaceuticals
Foods
Beverages
Feeds Industries

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the GABA (Gamma-Aminobutyric Acid) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key GABA (Gamma-Aminobutyric Acid) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of GABA (Gamma-Aminobutyric Acid) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

Frequently Asked Questions